Loading organizations...

§ Private Profile · San Leandro, CA, USA
develops and sells affordable, at-home programmable hearing aids and FDA-cleared hearing screeners for mild-to-moderate hearing loss.
iHear Medical, based in San Leandro, California, USA, is a direct-to-consumer company developing and selling affordable, at-home programmable hearing aids and FDA-cleared home hearing screeners for mild-to-moderate hearing loss. Its web-enabled devices, such as the iHEARhd and iHEARtest, are sold online to bypass traditional high costs, offering both preset and customized settings. Founded pre-2012 by Adnan Shennib, who also serves as CEO and is known as the inventor of the Lyric hearing aid, the company also features Varun Bhardwaj as VP Operations. iHear Medical has successfully secured significant venture funding, including $1.8 million in second-round financing in 2012 and an additional $4.1 million in Series C-2 funding in 2017, led by Ameritas. Its investor base further includes notable firms like Aphelion Capital and Highlight Capital, supporting its mission to expand manufacturing and distribution.
iHear Medical has raised $13.2M across 4 funding rounds.
iHear Medical has raised $13.2M in total across 4 funding rounds.
iHear Medical has raised $13.2M in total across 4 funding rounds.
iHear Medical's investors include Ameritas Holding Company, Aphelion Capital, Lighthouse Capital, Minglie Hu, Brother Industries.
iHear Medical has raised $13.2M across 4 funding rounds. Most recently, it raised $2.3M Other Equity in September 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 22, 2017 | $2.3M Venture Round | Ameritas Holding Company, Aphelion Capital, Lighthouse Capital | — | Announced |
| Jan 19, 2017 | $4.1M Series C | Ameritas Holding Company | Aphelion Capital, Lighthouse Capital | Announced |
| Nov 24, 2014 | $5M Series C | Minglie HU | Ameritas Holding Company, Brother Industries | Announced |
| Feb 7, 2012 | $1.8M Venture Round | — | Aphelion Capital | Announced |